Physician profile
John H Bascome
NPI 1184927105
$20,686.62
in general payments reported to CMS, 2019-2025
21 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,990 · 2020: $2,367 · 2021: $437 · 2022: $1,199 · 2023: $1,073 · 2024: $289 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Food and Beverage: $1,403 · Consulting Fee: $260 · Entertainment: $86.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $11,445.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Food and Beverage | $1,403.11 |
| Consulting Fee | $260.00 |
| Entertainment | $86.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionary Optics LLC | $11,445.00 | 2025 | |
| Johnson & Johnson Vision Care, INC. | $2,210.34 | 2019-2025 | Acuvue |
| Oculus, INC. | $2,140.00 | 2020 | |
| Coopervision INC. | $2,096.68 | 2019-2025 | Onefit Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,754.47 | 2019-2020 | |
| Glaukos Corporation | $178.39 | 2021-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $145.26 | 2022 | |
| Shire North American Group INC | $140.10 | 2019 | |
| Optos, INC. | $107.70 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| New World Medical,INC. | $83.74 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $78.33 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $66.43 | 2022 | |
| Quidel Corporation | $59.13 | 2021 | |
| Dompe US, INC. | $57.26 | 2021-2025 | Oxervate |
| Biotissue Holdings INC. | $29.38 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $17.98 | 2022 | |
| Alcon Vision LLC | $17.48 | 2019 | |
| Sun Pharmaceutical Industries INC. | $15.58 | 2021 | |
| Alcon Research LLC | $15.47 | 2019 | |
| Sight Sciences, INC. | $14.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bascome listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.